Status:
UNKNOWN
Allogenic Cord Blood Transfusion in Patients With Cerebral Palsy
Lead Sponsor:
State-Financed Health Facility "Samara Regional Medical Center Dinasty"
Conditions:
Cerebral Palsy
Eligibility:
All Genders
1-10 years
Phase:
PHASE2
Brief Summary
Cerebral palsy is a disorder of movement and posture resulted from a non-progressive lesion or injury of the immature brain. It is a leading cause of childhood onset disability. Many experimental ani...
Detailed Description
Cerebral palsy (CP) is a group of neurodevelopmental conditions with abnormal movement and posture resulted from a non-progressive cerebral disturbance. It is the most common cause of motor disability...
Eligibility Criteria
Inclusion
- \- Confirmed diagnosis: Cerebral Palsy.
Exclusion
- the presence of the following diseases in history: heart failure in the stage of decompensation, stroke in history less than 1 year ago, blood diseases;
- decompensation of chronic and endocrinological diseases;
- acute respiratory viral and bacterial infections, period less than 1 month after the acute phase.
- HIV infection, hepatitis B and C.
- oncological diseases, chemotherapy in the anamnesis;
- tuberculosis.
Key Trial Info
Start Date :
January 12 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 26 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03826498
Start Date
January 12 2018
End Date
December 26 2024
Last Update
January 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical Centre Dinasty
Samara, Russia, 443095